Alzheimer's disease

Blister Packs for Several Meds Recalled Due to Risk of Harm to Children

By July 09, 2018

The recall affects approximately 470,000 units that include drugs packaged with 3 to 10 tablets per blister card. The blister packs were developed for use in hospitals, however some were sent to retail pharmacies and were likely dispensed for in-home use.

Treating Apathy in Alzheimer's Disease Patients: A Meta-Analysis

By May 11, 2018

Methylphenidate demonstrated an improvement in apathy vs placebo when measured by the apathy evaluation scale, in addition, methylphenidate showed possible improvement in cognition.

Study Evaluating Verubecestat in Prodromal Alzheimer's Disease Stopped

By February 14, 2018

APECS is a randomized, placebo-controlled, parallel-group, double-blind Phase 3 clinical trial evaluating the efficacy and safety of verubecestat in people with prodromal AD.

The Affects of Alzheimer's Disease on a Patient's Heart

November 29, 2016

Amyloid beta (Aβ) deposits in Alzheimer's patients might also negatively affect their heart muscle and increase their risk of heart failure, according to a study published in the Journal of the American College of Cardiology.

Benzodiazepine Users May Be at Increased Risk for Hip Fracture

By November 23, 2016

Benzodiazepines and related drugs were found to increase the risk of hip fracture in patients with Alzheimer's disease.

Results for Solanezumab in Mild Dementia of Alzheimer's Disease Announced

By November 23, 2016

Eli Lilly announced that solanezumab did not meet the primary endpoint in the Phase 3 EXPEDITION3 clinical trial in patients with mild dementia due to Alzheimer's disease.

Novel BACE Inhibitor in Development for Alzheimer's Disease

By November 17, 2016

Eisai announced that the Food and Drug Administration (FDA) has granted Fast Track designation for E2609 (Eisai and Biogen) in development for early Alzheimer's disease.

Stress in Elderly Linked to Onset of Cognitive Impairment

By December 14, 2015

Elderly people who experience chronic stress are twice as likely to develop mild cognitive impairment, which is a common prelude to full-blown Alzheimer's disease.

Moderate Drinking May Benefit Early-Stage Alzheimer's Patients

December 14, 2015

Patients with early-stage Alzheimer's disease who consume two to three alcoholic drinks a day may have a reduced risk of mortality compared to those who consume one or fewer drinks a day, according to a study published online December 11 in BMJ Open.

A Compound in Chamomile May Benefit Brain Cells

By December 11, 2015

Apigenin, a flavonoid found in some spices and herbs, may improve neuron formation and strengthen connections between brain cells, researchers from D'Or Institute for Research and Education reported.

Slow Gait in Seniors may be Indicative of Alzheimer's

December 04, 2015

Seniors who walk more slowly may have higher amounts β-amyloid (Aβ) in their brains, according to research published online in Neurology.

Can Raloxifene Improve Cognitive Function in Alzheimer's Dementia?

By November 05, 2015

Raloxifene does not appear to have a beneficial effect on memory and thinking skills in women with dementia due to Alzheimer's disease, a recent study has shown.

Targeted Immune Therapy: The Next Alzheimer's Treatment?

September 08, 2014

Targeted stimulation of the immune system in mice has led to the removal of amyloid plaque formation, (a known marker of Alzheimer's disease), according to researchers at NYU Langone Medical Center.